Manufacturer
Avyxa Pharma
- Products listed
- 29
- Molecules
- 14
- Therapy areas
- 2
Avyxa Pharma is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 29 of its products across 14 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- AVYXA Pharma, LLC, Avyxa Pharma, LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Avyxa Pharma products through licensed channels, with the documents your regulator needs.
Oncology
24 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Avgemsi 1998.8 mg/52.6 mL injectionIntravenous Cold chain | Gemcitabine | US FDA | Available on request |
| Avgemsi 999.4 mg/26.3 mL injectionIntravenous Cold chain | Gemcitabine | US FDA | Available on request |
| Avopef 100 mg/5 mL injectionIntravenous | Etoposide | US FDA | Available on request |
| Avopef 500 mg/25 mL injectionIntravenous | Etoposide | US FDA | Available on request |
| Axtle 100 mg/4 mL powder for injectionIntravenous | Pemetrexed | US FDA | Available on request |
| Axycis 50 mg/50 mL injectionIntravenous | Cisplatin | US FDA | Available on request |
| Bendamustine 100 mg/4 mL injectionIntravenous Cold chainGeneric name | Bendamustine | US FDA | Available on request |
| Cligavyx 250 mg/5 mL injectionIntramuscular Cold chain | Fulvestrant | US FDA | Available on request |
| Cyclophosphamide 1 g/2 mL injectionIntravenous Cold chainGeneric name | Cyclophosphamide | US FDA | Available on request |
| Cyclophosphamide 2 g/4 mL injectionIntravenous Cold chainGeneric name | Cyclophosphamide | US FDA | Available on request |
| Cyclophosphamide 500 mg/1 mL injectionIntravenous Cold chainGeneric name | Cyclophosphamide | US FDA | Available on request |
| Docivyx 160 mg/16 mL injectionIntravenous | Docetaxel | US FDA | Available on request |
| Docivyx 20 mg/2 mL injectionIntravenous | Docetaxel | US FDA | Available on request |
| Docivyx 80 mg/8 mL injectionIntravenous | Docetaxel | US FDA | Available on request |
| Favlyxa 250 mg/10 mL injectionIntravenous | Fluorouracil | US FDA | Available on request |
| Favlyxa 2500 mg/100 mL injectionIntravenous | Fluorouracil | US FDA | Available on request |
| Frindovyx 1 g/2 mL injectionIntravenous Cold chain | Cyclophosphamide | US FDA | Available on request |
| Frindovyx 2 g/4 mL injectionIntravenous Cold chain | Cyclophosphamide | US FDA | Available on request |
| Frindovyx 500 mg/1 mL injectionIntravenous Cold chain | Cyclophosphamide | US FDA | Available on request |
| Gobarden 100 mg/4 mL injectionIntravenous Cold chain | Bendamustine | US FDA | Available on request |
| Kyxata 500 mg/50 mL injectionIntravenous | Carboplatin | US FDA | Available on request |
| Kyxata 80 mg/8 mL injectionIntravenous | Carboplatin | US FDA | Available on request |
| Lutrate Depot kit | Leuprolide | US FDA | Available on request |
| Pemetrexed 500 mg/20 mL powder for injectionIntravenousGeneric name | Pemetrexed | US FDA | Available on request |
Gastroenterology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Navitrux 150 mg/5 mL powder for injectionIntravenous Cold chain | Fosaprepitant | US FDA | Available on request |
| posfrea 0.25 mg/5 mL injectionIntravenous | Palonosetron | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vykoura 350 mg/35 mL injectionIntramuscular, intravenous Cold chain | Leucovorin | US FDA | Available on request |
| Vykoura 50 mg/5 mL injectionIntramuscular, intravenous Cold chain | Leucovorin | US FDA | Available on request |
| Vykoura 500 mg/50 mL injectionIntramuscular, intravenous Cold chain | Leucovorin | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Avyxa Pharma
Send a request for any of these products. We confirm the licensed source, documents and lead time.